[Silent myocardial ischemia. Arguments against treatment].
Rayo Llerena
I
I
Servicios de Cardiología, Hospital 12 de Octubre, Madrid.
Marín Huerta
E
E
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000787:Angina Pectoris / Q000175:diagnosis / Q000188:drug therapy; D000789:Angina, Unstable / Q000175:diagnosis / Q000188:drug therapy; D001262:Atenolol / Q000627:therapeutic use; D017298:Bisoprolol / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004562:Electrocardiography; D015716:Electrocardiography, Ambulatory; D005080:Exercise Test; D006801:Humans; D015337:Multicenter Studies as Topic; D009203:Myocardial Infarction / Q000150:complications; D017202:Myocardial Ischemia / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D009204:Myocardial Revascularization; D009543:Nifedipine / Q000627:therapeutic use; D011379:Prognosis; D013565:Sympatholytics / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D013565:Sympatholytics; D001262:Atenolol; D009543:Nifedipine; D017298:Bisoprolol
Isquemia miocárdica silente. Argumentos en contra de su tratamiento.